Mid-term clinical outcomes and cardiac function in patients receiving cardiac contractility modulation
Journal of Interventional Cardiac Electrophysiology · 2024
DOI: 10.1007/s10840-024-01900-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Interventional Cardiac Electrophysiology, 2024. Verfasst von Andrew Deak und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Section of Cardiology, Parkinson Pavilion, 9th Floor, 3401 North Broad Street, Philadelphia, PA, 19140, USA. Hauptthemen laut MEDLINE: Myocardial Contraction, Electric Stimulation Therapy, Heart Failure, Systolic. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To describe the mid-term clinical and functional cardiac contractility modulation therapy (CCM) recipients in an urban population with heart failure.
Background
CCM is a non-excitatory electrical therapy for patients with systolic heart failure with NYHA class III symptoms and ejection fraction (EF) 25–45%. How CCM affects a broad range of clinical measures, including diastolic dysfunction (DD) and weight change, is unexplored.
Methods
We reviewed 31 consecutive patients at our center who underwent CCM implant. NYHA class, hospitalizations, ejection fraction (EF), diastolic function, and weight were compared pre- and post-CCM implant.
Results
Mean age and follow-up time was 63 ± 10 years and 1.4 ± 0.8 years, respectively. Mean NYHA class improved by 0.97 functional classes ( p < 0.001), and improvement occurred in 68% of patients. Mean annualized hospitalizations improved (0.8 ± 0.8 vs. 0.4 ± 1.0 hospitalizations/year, p = 0.048), and after exclusion of a single outlier, change in annualized days hospitalized also improved (total cohort 3.8 ± 4.7 vs. 3.7 ± 14.8 days/year; p = 0.96; after exclusion, 3.8 ± 4.7 vs. 1.1 ± 1.9 days/year, p < 0.001). Mean EF improved by 8% ( p = 0.002), and among those with DD pre-CCM, mean DD improvement was 0.8 “grades” ( p < 0.001). Mean weight change was 8.5 pounds lost, amounting to 4% of body weight ( p = 0.002, p = 0.002, respectively), with 77% of patients having lost weight after CCM. Five patients (16%) experienced procedural complications; incidence skewed toward early implants.
Conclusion
In an observational cohort, CCM therapy resulted in improvement in NYHA class, hospitalizations, systolic and diastolic function, and weight. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Section of Cardiology, Parkinson Pavilion, 9th Floor, 3401 North Broad Street, Philadelphia, PA, 19140, USA.
- Department of Medicine, Section of Cardiology, Parkinson Pavilion, 9th Floor, 3401 North Broad Street, Philadelphia, PA, 19140, USA. Isaac.Whitman@tuhs.temple.edu.
Zitieren
APA
Deak, A., Zaidi, S. M., Gangireddy, C., Cronin, E., Hamad, E., Fabrizio, C., Bhatia-Patel, S., Rakita, V., & Whitman, I. R. (2024). Mid-term clinical outcomes and cardiac function in patients receiving cardiac contractility modulation. Journal of Interventional Cardiac Electrophysiology. https://doi.org/10.1007/s10840-024-01900-0
Vancouver
Deak A, Zaidi SM, Gangireddy C, Cronin E, Hamad E, Fabrizio C, et al. Mid-term clinical outcomes and cardiac function in patients receiving cardiac contractility modulation. Journal of Interventional Cardiac Electrophysiology. 2024. doi:10.1007/s10840-024-01900-0
BibTeX
@article{Deak2024,
author = {Deak, Andrew and Zaidi, Syed M and Gangireddy, Chethan and Cronin, Edmond and Hamad, Eman and Fabrizio, Carly and Bhatia-Patel, Sanjana and Rakita, Val and Whitman, Isaac R},
title = {Mid-term clinical outcomes and cardiac function in patients receiving cardiac contractility modulation},
journal = {Journal of Interventional Cardiac Electrophysiology},
year = {2024},
doi = {10.1007/s10840-024-01900-0}
}
EUVIMED